causal
Analysis v1
Strong Support
For people at high risk for heart problems because of diabetes or clogged arteries, taking a drug called evolocumab every two weeks can lower their chances of having a heart attack, stroke, or needing heart surgery by about 1 in 5 over nearly 5 years, compared to those who don’t take it.
95
0
Evidence from Studies
Supporting (1)
95
Community contributions welcome
95
Evolocumab in Patients without a Previous Myocardial Infarction or Stroke.
Randomized Controlled Trial
Human
2026 Jan 8The study tested the exact same drug, dose, and type of patients as in the claim, and found it reduced heart problems by 19%, just like the claim says.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.